CloudMD Gets Price Target Cut By Canaccord Genuity

On Monday CloudMD Software & Services Inc. (TSXV: DOC) reported its fourth quarter results for the period ended December 31, 2021. The company reported revenues of $38.7 million, down sequentially. The company attributes this decline to the completion of its COVID testing contracts. Gross margins also contracted, dropping to 30% from 34% last quarter and 40.4% last year.

The company reported adjusted EBITDA of $0.6 million, slightly below the $0.8 million figure posted last year, and earnings per share of $0.06, or net income of $15.1 million. The firm ended the year with $45.1 million in cash on hand.

CloudMD currently has 7 analysts covering the stock with an average 12-month price target of C$2.41, or an upside of 375%. Out of the 7 analysts, 2 have strong buy ratings and the other 5 analysts have buy ratings. The street high sits at C$5, which represents an upside of 880% to the current price.

Nord Precious Metals — sponsored Sponsored · Nord Precious Metals

In Canaccord Genuity’s note on the results, the firm reiterates its speculative buy rating but slashed its 12-month price target from C$3.00 to C$1.50. Canaccord comments that they continue to look ahead for profitability, which will help the company de-risk from being a growth company as Canaccord believes the market is currently favoring profitability over growth.

On the results, Canaccord says that the company beat slightly on revenues as their estimate was $37.3 million, while the company missed on their $1.2 million adjusted EBITDA estimate. They also note that the company’s free cash flow was impacted by a one-time M&A deal and accounts receivable issues. The company saw a $3.4 million charge related to these issues.

Additionally, Canaccord says that going forward they expect the MindBeacon acquisition growth will overshadow any organic growth. While they believe that the latest management musical chairs adds another element of risk to the company.

Lastly, Canaccord has cut their estimates going forward as they factor in lost US revenue from the VisionPros business and higher employee costs.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Canaccord Lowers Targets On Numerous Top Level Cannabis Equities

On February 4th, Canaccord Genuity came out with their cannabis fourth quarter 2021 preview. On...

Monday, February 7, 2022, 01:30:00 PM

Hexo Sees Revenues Decline 31% To $22.7 Million In Q3 2021

Hexo Corp (TSX: HEXO) (NYSE: HEXO) this morning reported a doozy of a quarter. The...

Monday, June 14, 2021, 08:40:27 AM

Equinox Gold: Canaccord Reiterates Buy Rating, $12 Price Target

Early this month, Equinox Gold Corp. (TSX: EQX) reported its third quarter financial results. The...

Tuesday, November 23, 2021, 02:48:00 PM

Uranium: Cantor Increases Spot Price Target To As High As $150 For U3O8

Following guidance reductions from uranium mining major Kazatomprom, at least one analyst is calling for...

Saturday, February 3, 2024, 09:27:00 AM

Kirkland Lake: Canaccord Maintains $68 Price Target, Buy Rating

On Wednesday, July 1, during market hours Kirkland Lake Gold (TSX: KL) reissued it’s 2020...

Thursday, July 2, 2020, 12:12:07 PM